(VIANEWS) - Petroleo Brasileiro (PBR), Vital Farms (VITL), DexCom (DXCM) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Petroleo Brasileiro (PBR)
60.5% sales growth and 33.91% return on equity
Petróleo Brasileiro S.A. - Petrobras produce and sells oil and gas in Brazil and internationally.
Petroleo Brasileiro's sales growth this year is expected to be 45.1% and 3.2% for next year.
Year-on-year quarterly revenue growth grew by 111.6%, now sitting on 299.02B for the twelve trailing months.
Volume
Today's last reported volume for Petroleo Brasileiro is 11802300 which is 59.22% below its average volume of 28947400.
Petroleo Brasileiro's sales growth for the next quarter is 60.5%. The company's growth estimates for the current quarter and the next is 1425% and negative -22.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 33.91%.
Volatility
Petroleo Brasileiro's last day, last week, and last month's current intraday variation average was 1.44%, 1.89%, and 2.01%, respectively.
Petroleo Brasileiro's highest amplitude of average volatility was 2.18% (day), 2.18% (last week), and 2.63% (last month), respectively.
Petroleo Brasileiro's Stock Yearly Top and Bottom Value
Petroleo Brasileiro's stock is valued at $10.94 at 15:22 EST, way under its 52-week high of $12.38 and way above its 52-week low of $7.06.
Petroleo Brasileiro's Moving Average
Petroleo Brasileiro's worth is above its 50-day moving average of $10.41 and higher than its 200-day moving average of $10.50.Previous days news about Petroleo Brasileiro(PBR)
- According to Bloomberg Quint on Wednesday, 15 December, "His latest move atMubadala was the acquisition ofa refinery in the northeastern state of Bahia from state-controlled oil giant Petroleo Brasileiro SA, which is shedding assets to reducedebt."
- According to Bloomberg Quint on Thursday, 16 December, "In an auction on Friday, Exxon Mobil Corp., Royal Dutch Shell Plc and eight other applicants will be looking at a 70% cheaper signing bonus than two years ago to bid for partnerships with Petroleo Brasileiro SA in the Sepia and Atapu fields in ultra-deep waters of the South Atlantic."
- According to Bloomberg Quint on Thursday, 16 December, "Under Chief Executive Officer Gustavo Montezano, the lender has sold stakes in firms including state-owned Petroleo Brasileiro SA, pulp maker Suzano SA, miner Vale SA and paper-packaging producer Klabin SA."
2. Vital Farms (VITL)
26.3% sales growth and 3.65% return on equity
Vital Farms, Inc. operates as an ethical food company in the United States.
Vital Farms's sales growth this year is expected to be 18.8% and 26.4% for next year.
Year-on-year quarterly revenue growth grew by 21.1%, now sitting on 237.49M for the twelve trailing months.
Volume
Today's last reported volume for Vital Farms is 29347 which is 88.29% below its average volume of 250761.
Vital Farms's sales growth for the next quarter is 26.3%. The company's growth estimates for the ongoing quarter and the next is a negative 350% and negative -87.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.65%.
Volatility
Vital Farms's last day, last week, and last month's current intraday variation average was 3.68%, 2.51%, and 2.82%, respectively.
Vital Farms's highest amplitude of average volatility was 6.33% (day), 4.73% (last week), and 4.99% (last month), respectively.
Vital Farms's Stock Yearly Top and Bottom Value
Vital Farms's stock is valued at $16.85 at 15:22 EST, way under its 52-week high of $31.24 and way higher than its 52-week low of $15.14.
Vital Farms's Moving Average
Vital Farms's value is under its 50-day moving average of $17.72 and way under its 200-day moving average of $19.93.3. DexCom (DXCM)
19.5% sales growth and 31.66% return on equity
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DexCom's sales growth this year is expected to be 24.3% and 21.8% for next year.
Year-on-year quarterly revenue growth grew by 31.7%, now sitting on 2.17B for the twelve trailing months.
Volume
Today's last reported volume for DexCom is 587072 which is 11.97% below its average volume of 666936.
DexCom's sales growth is a negative 0% for the ongoing quarter and 19.5% for the next. The company's growth estimates for the present quarter and the next is a negative 33% and negative -15.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.66%.
Volatility
DexCom's last day, last week, and last month's current intraday variation average was 2.25%, 5.35%, and 2.66%, respectively.
DexCom's highest amplitude of average volatility was 3.32% (day), 3.54% (last week), and 3.36% (last month), respectively.
DexCom's Stock Yearly Top and Bottom Value
DexCom's stock is valued at $560.63 at 15:22 EST, way under its 52-week high of $659.45 and way higher than its 52-week low of $318.45.
DexCom's Moving Average
DexCom's value is under its 50-day moving average of $583.08 and way higher than its 200-day moving average of $471.41.Previous days news about DexCom(DXCM)
- According to Benzinga on Monday, 13 December, "The other two stocks that make up the top five holdings in the AMOM portfolio are software company Autodesk with a 2.5% weighting and glucose monitoring systems maker DexCom Inc. (NASDAQ:DXCM) with 2.4%."
4. Magellan Midstream Partners L.P. Limited Partnership (MMP)
17.3% sales growth and 42.08% return on equity
Magellan Midstream Partners, L.P. engages in the transportation, storage, and distribution of refined petroleum products and crude oil in the United States.
Magellan Midstream Partners L.P. Limited Partnership's sales growth this year is expected to be 9.9% and 3.8% for next year.
Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 2.59B for the twelve trailing months.
Volume
Today's last reported volume for Magellan Midstream Partners L.P. Limited Partnership is 1742550 which is 42.53% above its average volume of 1222560.
Magellan Midstream Partners L.P. Limited Partnership's sales growth for the next quarter is 17.3%. The company's growth estimates for the ongoing quarter and the next is 4.3% and 26.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.08%.
Volatility
Magellan Midstream Partners L.P. Limited Partnership's last day, last week, and last month's current intraday variation average was 1.28%, 1.07%, and 1.17%, respectively.
Magellan Midstream Partners L.P. Limited Partnership's highest amplitude of average volatility was 1.69% (day), 1.78% (last week), and 2.27% (last month), respectively.
Magellan Midstream Partners L.P. Limited Partnership's Stock Yearly Top and Bottom Value
Magellan Midstream Partners L.P. Limited Partnership's stock is valued at $45.14 at 15:22 EST, way under its 52-week high of $53.85 and way higher than its 52-week low of $39.93.
Magellan Midstream Partners L.P. Limited Partnership's Moving Average
Magellan Midstream Partners L.P. Limited Partnership's worth is under its 50-day moving average of $47.85 and under its 200-day moving average of $47.57.5. Intuitive Surgical (ISRG)
14% sales growth and 12.67% return on equity
Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally.
Intuitive Surgical's sales growth this year is expected to be 29.5% and 13.1% for next year.
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 4.55B for the twelve trailing months.
Volume
Today's last reported volume for Intuitive Surgical is 1228180 which is 25.44% below its average volume of 1647350.
Intuitive Surgical's sales growth for the next quarter is 14%. The company's growth estimates for the present quarter and the next is 26.7% and 4.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.67%.
Volatility
Intuitive Surgical's last day, last week, and last month's current intraday variation average was 3.12%, 2.98%, and 1.42%, respectively.
Intuitive Surgical's highest amplitude of average volatility was 2.56% (day), 2.56% (last week), and 2.31% (last month), respectively.
Intuitive Surgical's Stock Yearly Top and Bottom Value
Intuitive Surgical's stock is valued at $341.28 at 15:22 EST, way below its 52-week high of $1,087.01 and higher than its 52-week low of $313.69.
Intuitive Surgical's Moving Average
Intuitive Surgical's value is below its 50-day moving average of $342.54 and way under its 200-day moving average of $730.36.Previous days news about Intuitive Surgical(ISRG)
- According to Bloomberg Quint on Sunday, 12 December, "In China, it also sells foreign brands like a key cancer therapy marketed by Gilead Sciences Inc. and surgical robots made by Intuitive Surgical Inc."
- According to Benzinga on Monday, 13 December, "From surgical robots that can precisely perform surgeries like those developed by Intuitive Surgical Inc. (NASDAQ: ISRG) and Stryker Corp. (NYSE: SYK) to assembling automobiles, teaching and making music, robots are transforming the way we live and work."
6. Darling Ingredients (DAR)
11% sales growth and 17.88% return on equity
Darling Ingredients Inc. develops, produces, and sells natural ingredients from edible and inedible bio-nutrients.
Darling Ingredients's sales growth this year is anticipated to be 29.7% and 2.5% for next year.
Year-on-year quarterly revenue growth grew by 39.4%, now sitting on 4.45B for the twelve trailing months.
Volume
Today's last reported volume for Darling Ingredients is 1434380 which is 6.9% above its average volume of 1341780.
Darling Ingredients's sales growth for the next quarter is 11%. The company's growth estimates for the present quarter and the next is 135.6% and 51.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.88%.
Volatility
Darling Ingredients's last day, last week, and last month's current intraday variation average was 0.52%, 1.68%, and 2.09%, respectively.
Darling Ingredients's highest amplitude of average volatility was 2.51% (day), 4.24% (last week), and 3.68% (last month), respectively.
Darling Ingredients's Stock Yearly Top and Bottom Value
Darling Ingredients's stock is valued at $63.72 at 15:22 EST, way under its 52-week high of $85.98 and way higher than its 52-week low of $53.78.
Darling Ingredients's Moving Average
Darling Ingredients's worth is way below its 50-day moving average of $74.60 and way under its 200-day moving average of $72.14.7. E.W. Scripps Company (SSP)
8.5% sales growth and 12.55% return on equity
The E.W. Scripps Company, together with its subsidiaries, operates as a media enterprise through a portfolio of local and national media brands.
E.W. Scripps Company's sales growth this year is anticipated to be 23% and 15.6% for next year.
Year-on-year quarterly revenue growth grew by 12.6%, now sitting on 2.25B for the twelve trailing months.
Volume
Today's last reported volume for E.W. Scripps Company is 317716 which is 23.87% above its average volume of 256477.
E.W. Scripps Company's sales growth for the next quarter is 8.5%. The company's growth estimates for the present quarter and the next is a negative 59.3% and 1266.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.55%.
Volatility
E.W. Scripps Company's last day, last week, and last month's current intraday variation average was 1.26%, 1.08%, and 1.87%, respectively.
E.W. Scripps Company's highest amplitude of average volatility was 2.76% (day), 2.88% (last week), and 3.65% (last month), respectively.
E.W. Scripps Company's Stock Yearly Top and Bottom Value
E.W. Scripps Company's stock is valued at $20.02 at 15:22 EST, way below its 52-week high of $24.78 and way above its 52-week low of $13.34.
E.W. Scripps Company's Moving Average
E.W. Scripps Company's value is above its 50-day moving average of $19.37 and above its 200-day moving average of $19.83.8. First Industrial Realty Trust (FR)
6.5% sales growth and 12.4% return on equity
First Industrial Realty Trust, Inc. (NYSE: FR) is a leading fully integrated owner, operator, and developer of industrial real estate with a track record of providing industry-leading customer service to multinational corporations and regional customers.
First Industrial Realty Trust's sales growth this year is anticipated to be 6.4% and 8.4% for next year.
Year-on-year quarterly revenue growth grew by 4.3%, now sitting on 464.48M for the twelve trailing months.
Volume
Today's last reported volume for First Industrial Realty Trust is 4408530 which is 448.84% above its average volume of 803246.
First Industrial Realty Trust's sales growth for the next quarter is 6.5%. The company's growth estimates for the ongoing quarter and the next is a negative 60% and negative -41.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.4%.
Volatility
First Industrial Realty Trust's last day, last week, and last month's current intraday variation average was 1.05%, 1.11%, and 0.87%, respectively.
First Industrial Realty Trust's highest amplitude of average volatility was 1.36% (day), 1.68% (last week), and 1.76% (last month), respectively.
First Industrial Realty Trust's Stock Yearly Top and Bottom Value
First Industrial Realty Trust's stock is valued at $63.77 at 15:22 EST, under its 52-week high of $64.21 and way higher than its 52-week low of $40.08.